Segmed's ASCO 2024 Insights with Taylor Duguay

Segmed recently participated in the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Taylor Duguay, Segmed’s Director of Clinical Development, attended the event at McCormick Place and shares his insightful experience below.

‍

First Impressions

The American Society of Clinical Oncology Annual Meeting is a pinnacle event in the world of oncology and ASCO 2024 did not fall short. Forty-thousand oncologists, healthcare professionals, researchers, and industry leaders from across the globe gathered to exchange the latest in groundbreaking research and novel therapies. McCormick Place featured an expansive Exhibit Hall which included a dedicated Poster Session area where hundreds of researchers presented their research to what seemed to be a continuous flow of attendees. With four days of sessions, there was more to see and experience than time allowed.

‍

Research & Presentations

The poster sessions showcased significant advancements in oncology, often supported by real-world data (RWD). The "Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology" session discussed new targeted therapies that improve patient outcomes. Breakthroughs in immunotherapy were a key focus in the "Developmental Therapeutics—Immunotherapy" session, showing its efficacy and safety across diverse populations. The breast cancer sessions, both local/regional/adjuvant and metastatic, demonstrated advancements in treatment protocols and management of long-term effects, with RWD playing a critical role. 

Despite the emphasis on real-world data (RWD) in many aspects of oncology research and patient care, the integration of real-world imaging data (RWiD) was conspicuously lacking. This absence represents a missed opportunity, as real-world imaging data is crucial for comprehensive patient monitoring, treatment planning, and outcome assessment.

From the perspective of a company specializing in real-world imaging data, this gap underscores the need to advocate for the inclusion of imaging data in future research. By integrating imaging data with other RWD, we can provide a more complete picture of patient health, enhance predictive analytics, and ultimately improve cancer care outcomes.

‍

Networking & Collaboration

ASCO 2024 provided a unique opportunity for networking and collaboration with a global community dedicated to improving cancer care. Segmed met with several industry leaders and had fruitful discussions on how real-world imaging data can play a significant role in developing novel therapies. These conversations highlighted the critical importance of integrating imaging data with other real-world data sources to enhance research.

Segmed engaged with researchers and clinicians who acknowledged the potential of imaging data to provide deeper insights into tumor characteristics, treatment responses, and disease progression. By leveraging this data, we can support the development of more precise and personalized therapies, ultimately leading to better patient outcomes.

‍

Reflections & Final Thoughts 

Overall, ASCO 2024 was a testament to the ongoing progress in oncology and the collaborative efforts needed to push the boundaries of cancer care. As we reflect on the event, Segmed remains dedicated to advancing the integration of real-world imaging data into oncology research, driving innovation, and ultimately improving the lives of cancer patients worldwide.

‍

Get in Touch to Discover Segmed Solutions

Segmed's participation at ASCO 2024 underscored the critical role that real-world imaging data can play in advancing oncology research and improving patient outcomes. If you’re passionate about revolutionizing cancer care and want to learn more about how Segmed’s innovative medical imaging solutions can enhance your research or clinical practice, we’d love to hear from you.

‍

Connect with us today to explore how real-world imaging data can transform your approach to oncology, bringing you closer to groundbreaking discoveries and more effective treatments.

‍

Contact us now to learn more about Segmed solutions!